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ABSTRACT: Parinamashoola is a very common clinical problem in our day to day practice.  Its 
clinical picture is very much similar to non ulcer dyspepsia and peptic ulcer disease. 
Dhatrilauha is herbomineral compound drug.  Which is being used in Ayurveda for same.  The 
present study was planned to assess the efficacy of Dhatrilauha on scientific parameters  in this 
study total number of cases were taken into account and divided in to trial and control group  in 
control group a modern proved drug ranitidine is taken to compare the results this study 
produced very promising results of trial drug. 
 
INTRODUCTION  
 
Parinamashoola  is one common clinical 
problem of our day to day practice, it is very 
well described in ayurvedic texts of latter 
periods. On analizing it in modern light, its 
description is very much similar to peptic 
ulcer disease and which is well known 
established entity.  Its incidence is 
increasing rapidly day by day, since last few 
decades, most appropriate explanation for 
this, may be due to more stresses and strain 
in today’s life because of rapid urbanization 
and mordenistion.  It commonly affects 5-
10% of people, at any stage of their life. 
 
Introduction of endoscopy in the field of 
medicine, revolutionized the diagnosis of 
peptic ulcer and also differentiated from 
other similar disease (like Non Ulcer 
dyspepsia). 
 
The study and use of crude drugs is one of 
the oldest of medical sciences.  Cruds drugs 
have always constituted more than half of 
the remedial agents in use at any time 
(Ferguson 1958).  A number of drugs are 
available for treatment of peptic ulcer 
disease, including non ulcer dyspepsia.   
These are not easily available to all the 
patients, due the their high cost and some of 
them can not be used due to certain side 
effects also permanent cure of this disease is 
not possible yet, because of tits nature of 
recurrence. 
 
Various drugs are also described in 
Ayurvedic texts, for management of 
Parinamashoola.  These are being 
commonly used by Ayurvedic clinician, 
since long time.  Dhatrilauha, is very 
popular herbominerla compound (drug) and 
described for management of 
Parinamashoola. 
 
In the present clinical study, Dhatrilauha is 
taken into account, to see, its effect I 
patients of Parinamashoola, on the basis of 
scientific parameters. Effect of Dhatrilauha 
was also compared with ranitidine, a modern 
drug. 
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MATERIALS AND METHODS  
 
The present clinical stud was conducted in 
uncomplicated cases of Parinamashoola.  
Selection of patients was done randomly 
from Kayachikitsa (O.P.D and I.P.D) and 
gastroenterology, O.P.D., S.S. Hospital, 
B.H.U., Varanasi. Cases for this study were 
selected during the September 1991 to 
November 1992. 
 
The detailed symptomatic case history, 
demographic profile was recorded according 
to proforma prepared.  After clinical 
examination, they were subjected to 
necessary modern laboratory, radiological 
(Barium contrast examination) and 
endoscopic examination, then diagnosis was 
confirmed and trial drug was given. 
 
In this study total number of 30 cases were 
taken and they were divided into two 
groups: 
 
(a) Group ‘A’ 
 
This group was comprised of 20 patients. 
Out of 20 cases, there were 5 cases of peptic 
ulcer (Gastric or duodenal) and 15 cases of 
Non ulcer dyspepsia, having no peptic ulcer 
dyspepsia, having no peptic ulcer like 
finding on radiological and endoscopic 
examination, all of these patients were 
subjected to trial drug, Dhatrilauha, in the 
dose of 1gm x 3, divided doses per day.  The 
duration of treatment was kept 6 weeks. 
 
(b) Group ‘B’  
 
This group was comprised of 3 cases of 
peptic ulcer and 7 cases of Non- ulcer – 
dyspepsia.  Thus total numbe5 of cases was 
10. All these patients were kept on 
ranitidine, 150 mg x b.d. for six weeks. 
 
Clinical Profile  
 
The symptom and sign were graded, on a 
0,1,2,3 scale, for statistical valuation as 
follows: 
 
0-Absent 2-Moderate 1- Mild 3- Severe 
 
Grading of common symptoma tology was 
done in above manners. 
 
Drug 
 
Dhatrilauha is very popular herbomineral 
compound.  It is being used in the cases of 
parinamashoola since ears.  In the present 
clinical stud, this compound drug is taken, to 
see the efficacy of this drug is taken, to see 
the efficacy of this drug in t patients of 
parinamashoola.  The drug was prepared in 
Ayurvedic pharmacy, I.M.S., B.H.U., Its 
constituents are: 
 
1.  Amalaki powder (4 part) 
2.  Yashtimadhu Powder (1 Part) 
3.  Lauha Bhasma (2 part) 
 
The dose of drug was given in this clinical 
study, 1 gm in 3 divided doses per day with 
honey.  The duration was kept 6 weeks. 
 
Parameters of Assessment of Result 
 
The effect of Dhatrilauha was compared 
with modern drug ranitidine.  The following 
parameters were adopted for the assessment 
of response and its comparison. 
 
1.  Clinical: Symptomatic relief, in term’s 
relief in major symptom like pain in 
abdomen, heartburn, nausea, Vomiting 
etc.  This was evaluated on the basis of 
favorable shift of grades of symptom and 
signs in terms of statistical analysis. 
 
2.  Radiological: in the positive cases, 
improvement was assessed on the basis o 
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healing of ulcer by demonstration of 
well formed duodenal cap, decreased 
size of ulcer crater, fibrotic changes and 
increases distensibility. 
 
3.  Endoscopic: Assessment of peptic ulcer 
was done on the basis of healing of ulcer 
(complete or partical), decreased 
hyperaemia and reduced surrounding 
oedema. 
 
In the cases of non ulcer dyspepsia, there 
was no ulcer like finding, but there was 
presence of reflex oesophagitis, gastritis 
(antral or fundal), duodenitis or deformed 
pylorus and duodenal bulb.  In these cases 
assessment was done on the basis of 
reduction or absence of above lesion. 
 
Criteria of response of Drug 
 
The result of drug was assessed n the basis 
of clinical symptomatology and 
improvement in radiological and endoscopic 
findings: 
 
1.  Excellent 
2.  Good 
3.  Poor 
4.  Unchanged 
 
RESULTS  
 
A total number of 30 patients of 
Parinamashoola are included in this study.   
The relevant data in respect of demographic 
and clinical profile were recorded and in 
each case evaluated. Some of the 
observations are exhibited in following tales. 
Demographic and clinical profile was 
recorded with a view to define the type of 
patients selected for present study. 
 
Table I 
Age in 8 cases of peptic ulcer and 22 cases of non ulcer dyspepsia 
 
Age Group  Peptic ulcer  Non Ulcer Dyspepsia 
(In years)  No. of patients  % age  No. of patients  % age 
11-20 
21-30 
31-40 
41-50 
51-60 
61 and above  
1 
3 
2 
2 
-- 
-- 
12.50 
37.50 
25.00 
25.00 
-- 
-- 
1 
8 
8 
-- 
5 
-- 
4.54 
36.36 
36.36 
-- 
22.72 
-- 
Total 8  100  22  100 
 
 
Table II 
Sex incidence in 8 cases of peptic ulcer and 22 cases of non ulcer dyspepsia 
 
Age Group  Peptic ulcer  Non Ulcer Dyspepsia 
(In years)  No. of patients  % age  No. of patients  % age 
Male 
Female 
4 
4 
50.00 
50.00 
9 
13 
40.91 
59.09 
Total 8  100.00  22  100.00 
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Table III 
Deha Prakrti in 8 cases of peptic ulcer and 22 cases of non ulcer dyspepsia 
 
Deha Prakrti  Peptic ulcer  Non Ulcer Dyspepsia 
  No. of patients  % age  No. of patients  % age 
Vatika 
Paittika 
Kaphaja 
Vata-Paittika  
Vata–Kaphaja 
Pitta–Kaphaja  
-- 
1 
-- 
6 
1 
-- 
-- 
12.50 
-- 
75.00 
12.50 
-- 
3 
4 
1 
9 
3 
2 
13.64 
18.18 
4.55 
40.91 
13.64        
9.04 
Total 8  100  22  100 
 
Table IV 
Dietary incidence in 8 cases of peptic ulcer and 22 cases of non ulcer dyspepsia 
 
 Type of Diet  Peptic ulcer  Non Ulcer Dyspepsia 
  No. of patients  % age  No. of patients  % age 
Vegitarian 
Non  Vegitarian 
 
1 
7 
12.50 
87.50 
12 
10 
54.55 
45.55 
Total 8  100.00  22  100.00 
 
 
Table V 
Addiction in 8 cases of peptic ulcer and 22 cases of non ulcer dyspepsia 
 
Addition  Peptic ulcer  Non Ulcer Dyspepsia 
  No. of patients  % age  No. of patients  % age 
Tea and Coffee 
Smoking 
Tobacco and betal 
chewing  
None 
4 
2 
1 
 
1 
50.00 
25.00 
12.50 
 
12.50 
8 
3 
4 
 
7 
36.36 
13.63 
18.10 
 
31.80 
Total 8  100  22  100 
 
Table VI 
Blood group in 8 cases of peptic ulcer and 22 cases of non ulcer dyspepsia 
 
Blood group  Peptic ulcer  Non Ulcer Dyspepsia 
  No. of patients  % age  No. of patients  % age 
A* 
B* 
AB* 
1 
1 
3 
12.50 
12.50 
37.50 
2 
14 
1 
9.09 
63.64 
4.55 
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O* 3  37.50  5  22.73 
Total 8  100  22  100 
 
Radiological and Endoscopic Examination  
 
In the present clinical stud, each and every 
case of parinamashoola, i.e. diagnosed on 
clinical examination (symptomatic basis), is 
further subjected to radiological examination 
(Barium meal examination) and endoscopic 
examination for stomach and duodenum.   
Cases having positive findings of peptic 
ulcer were kept in peptic ulcer were kept in 
peptic ulcer group. 
 
Some of them having no positive findings of 
peptic ulcer, these cases were kept in non 
ulcer dyspepsia group.  Despite the positive 
radiological findings, only endoscopic 
confirmation of peptic ulcer was considered 
as of final criteria for diagnosis. 
 
The study reveals that, most commonly 
observed radiological findings in cases of 
Non Ulcer Dyspepsia are deformity of 
pylorus and duodenal bulb.  In same cases, 
this is also accompanied by surrounding 
oedematous appearance.  Before the 
introduction of endoscopy, marked 
deformity and irregularity of duodenal bulb 
was considered due to peptic ulcer, On 
endoscopic examination these cases showed 
findings like oesophagitis, gastritis (antral/ 
fundla) or duodenitis. Positive findings of 
peptic ulcer were absent.  Some cases also 
showed normal radiological and endoscopic 
findings. 
 
Cases of peptic ulcer group showed 
radiological findings of peptic ulcer, like 
ulcer crater I lesser curvature or I part of 
duodenum and irregular, deformed and 
oedematous pylorus or duodenal bulb.  The 
endoscopic examination revealed positive 
findings of peptic ulcer (maximum of 
duodenal ulcer in this study) in all the cases. 
 
Response of treatment 
 
Response of treatment of non Ulcer 
Dyspepsia (diagnose on radiological and 
edoscopic examination criteria) cases 
assessed on the symptomatic improvement. 
And Peptic Ulcer cases assessed on clinical, 
radiological and endoscopic improvement. 
 
(a) Clinical Improvement  
 
The following observations have been made 
form the response of treatment on reduction 
of mean symptoms score (Table VII). 
 
Table VII 
Reduction of Mean Difference of Symptom score in response to Treatment 
 
Symptoms Trial  Group Control  Group 
 Non  Ulcer 
Dyspepsia 
Peptic Ulcer   Non  Ulcer 
Dyspepsia 
Peptic Ulcer  
1. Pain in abdomen 
Mean ± SE 
t Value 
p value   
 
1.33 ± 0.23 
5.733 
<0.001 
 
1.4 ± 0.245 
5.714 
<0.01 
 
1.87 ± 0.245 
7.114 
<0.001 
 
1.667 ± 0.33 
5.006 
<0.05 
2. Acid eructation  
Mean ± SE 
 
0.93 ± 0.21 
 
0.8 ± 0.37 
 
0.572 ± 0.202 
 
1.0 
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t Value 
p value   
4.529 
<0.001 
2.139 
<0.05 
2.831 
<0.02 
-- 
-- 
3. Nausea 
Mean ± SE 
t Value 
p value   
 
 
0.667± 0.21 
3.176 
<0.01 
 
0 
-- 
-- 
 
0.429 ± 0.202 
2.123 
>0.05 
 
0.33 ± 0.33 
1.0 
>0.05 
4.Vomiting 
Mean ± SE 
t Value 
p value   
 
0.8 ± 0.17 
4.598 
<0.001 
 
0.2 ± 0.2 
1.0 
>0.05 
 
0.857 ± 0.340 
2.520 
<0.05 
 
1.33 ± 0.667 
1.999 
>0.05 
5. Anorexia 
Mean ± SE 
t Value 
p value   
 
0.4 ± 0.16 
2.454 
<0.05 
 
0.4 ± 0.245 
1.633 
>0.05 
 
0.429 ± 0.202 
2.112 
>0.05 
 
0.33 ± 0.333 
2.003 
>0.05 
6. Flatulence 
Mean ± SE 
t Value 
p value   
 
0.533 ± 0.133 
4.008 
<0.01 
 
0.4 ± 0.4 
1.0 
>0.05 
 
0.714 ± 0.488 
3.880 
<0.01 
 
0.667 ± 0.333 
2.003 
>0.05 
7. Constipation  
Mean ± SE 
t Value 
p value   
 
0.4 ± 0.131 
3.053 
<0.01 
 
0.6 ± 0.4 
1.5 
>0.05 
 
0.29 ± 0.202 
2.124 
<0.05 
 
1.333 ± 0.333 
4.003 
<0.05 
8. Indigestion 
Mean ± SE 
t Value 
p value   
 
0.667 ± 0.159 
4.195 
<0.001 
 
0.6 ± 0.4 
1.5 
>0.05 
 
0.429 ± 0.297 
2.124 
<0.05 
 
0 
-- 
-- 
9. Heartburn  
Mean ± SE 
t Value 
p value   
 
1.33 ± 0.186 
7.151 
<0.001 
 
1.2 ± 0.374 
3.209 
<0.05 
 
1.143 ± 0.261 
4.379 
<0.01 
 
1.33 ± 0.333 
3.993 
<0.05 
10. Water brash 
Mean ± SE 
t Value 
p value   
 
0.133±0.091 
1.462 
>0.05 
 
0.2±0.2 
1.0 
>0.05 
 
0.143 ±0.143 
1.0 
>0.05 
 
0.333 ± 0.333 
1.0 
>0.05 
11. Belching  
Mean ± SE 
t Value 
p value   
 
0.6 ±0.190 
3.158 
<0.01 
 
1.0 ±0.316 
3.165 
<0.05 
 
0.286 ±0.184 
1.554 
>0.05 
 
0.333 ± 0.333 
1.0 
>0.05 
12. Thirst 
Mean ± SE 
t Value 
p value   
 
0.333 ± 0.187 
1.781 
>0.05 
 
0.4 ± 0.245 
1.633 
>0.05 
 
0.286 ± 0.184 
1.554 
>0.05 
 
0.667 ± 0.667 
1.000 
>0.05 
13. Discomfort 
Mean ± SE 
t Value 
p value   
 
0.2 ± 0.107 
1.869 
>0.05 
 
0.2 ± 0.2 
1.0 
>0.05 
 
0.143 ± 0.143 
1.0 
>0.05 
 
0.333 ± 0.333 
1.0 
>0.05 
14. Heaviness 
Mean ± SE 
t Value 
 
0.267 ± 0.118 
2.263 
 
0.4 ± 0.245 
1.633 
 
0.286 ± 0.184 
1.554 
 
0 
-- 
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p value    >0.05  >0.05  > 0.05  -- 
15. Buring Sensation all 
over body  
Mean ± SE 
t Value 
p value   
 
 
0.333 ± 0.159 
2.094 
>0.05 
 
 
1.0 ± 0.159 
2.0 3.165 
3.0 <0.05 
 
 
0.429 ± 0.202 
2.124 
>0.05 
 
 
0.333 ± 0.333 
1.0 
>0.05 
  
Regarding pain in abdomen reduction of 
mean score is 1.33 ± 0.23 in Non Ulcer 
Dyspepsia, whereas in control group 1.857 ± 
0.26.  The peptic ulcer group as shown mean 
reduction of 1.4 ± 0.25 in trial group, 
whereas in control group it was 1.67 ± 0.33.  
It is evident that relief of pain in abdomen 
was statistically significant in all groups on 
Non Ulcer Dyspepsia and peptic ulcer, but 
comparatively more significant in control 
group. 
 
The response of acid eructation with the trial 
drug was highly significant (p< 0.001) in the 
Non Ulcer Dyspepsia and peptic ulcer and in 
the control group it was significant in peptic 
ulcer, but comparatively less in Non Ulcer 
Dyspepsia cases. 
 
The clinical symptom vomiting was 
responded well in Non Ulcer Dyspepsia 
cases of trial group (p< 0.001), than control 
group (p<0.05).  Whereas in peptic ulcer the 
symptom ad not sown any significant 
improvement (p< 0.05).  
 
The another symptom, heartburn was 
responded well in Non Ulcer Dyspepsia and 
peptic ulcer cases of both trial and control 
groups, but statistically highly significant 
response was seen in Non Ulcer Dyspepsia 
cases of trial group. 
 
Mild to moderate response was observed in 
symptom belching by the trial dug, whereas 
in control group the response was 
insignificant statistically.  The details of the 
remaining symptoms, their statistical values 
sown in table VII. 
 
(ii) Net response of clinical improvement in 
also assessed.  For this, first of all total score 
of symptoms before and after treatment is 
calculated for each patient, then difference 
of total score of reduction is recorded.  After 
this; percentage of total difference of score 
reduction from before total score is 
calculated.  If reduction of percentage is: 
 
75% or above – Excellent  
between 75 – 35% - Good 
Between 35 – 10% - Partial  
<10%   - Unchanged  
 
On the above methods, net results of clinics 
improvement is calculated and given in table 
VIII.
 
 
Table VIII 
Net response of clinical improvement 
 
Trial Group  Control Group   
Non Ulcer 
Dyspepsia  
Peptic Ulcer  Non  Ulcer 
Dyspepsia  
Peptic Ulcer 
Excellent 
Good 
4.67% 
53.33% 
60.00% 
20.00% 
71.42% 
28.58% 
100.00% 
-- 
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Partial  
Unchanged  
-- 
-- 
20.00% 
-- 
-- 
-- 
-- 
-- 
 
(B) Radiological Improvement   
 
This was assessed in all the cases of peptic 
ulcer by repeat barium meal examination, in 
both trial and control group (Table IX) 
 
The present study sows tat, there is mixed 
response obtained in radiological 
improvement, in both the groups. It may be 
due to that it required stud of long term 
duration. 
 
Table IX 
Radiological Improvement in 8 cases of peptic Ulcer 
 
Patient Name  Before Treatment  After Treatment  Conclusion 
TRIAL GROUP  
 
1.JC 
 
 
2. V 
 
 
 
 
3.GN 
 
 
 
4. A 
 
 
5.C 
 
 
 
CONTROL GROUP 
 
1.U 
 
 
 
2.R 
 
 
 
3.B 
 
 
Markedly deformed 
duodenal bulb  
 
Irregular duodenal 
bulb with ulcer crater 
in I part 
 
 
 
Markedly deformed 
duodenal bulb with 
mucosal oedema 
 
Small ulcer crater is 
seen in lesser 
curvature  
 
Markedly deformed 
duodenal bulb 
 
 
Small ulcer crater in I 
part of duodenon  
 
Mildly deformed 
duodenal bulb 
 
 
A ulcer crater on the 
lesser curvature of 
pyloric antrum with 
some deformity of 
 
 
Some rounding of 
duodenal bulb 
 
Shallow ulcer crater with 
persistant deformity of 
duodenal bulb  
 
Persistant deformity of 
duodenal bulb with 
absent oedema  
 
Persistant ulcer crater 
 
 
Rounding of duodenal 
bulb wit increased 
dispensability  
 
 
 
Shallow ulcer wit 
widened base 
 
 
Deformity of duodenal 
bulb persisting with some 
improvement  
 
Sallow ulcer crater with 
some increase 
dispensability   
 
 
Partial Healing  
 
 
Good healing  
 
 
 
 
Partial healing  
 
 
 
Persistant ulcer 
 
 
Marked healing  
 
 
 
 
 
Marked healing  
Of ulcer 
 
 
Partial healing 
 
 
Good healing   
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duodenal bulb  
 
(C)Endoscopic Improvement  
 
This was assessed in all the cases of peptic 
ulcer repeat endoscopic examination to see 
the effect on trial and control group (Table 
X)  
 
Table X 
Radiological Improvement in 8 Cases of Peptic Ulcer 
 
Patient Name  Before Treatment  After Treatment  Conclusion 
TRIAL GROUP  
1.JC 
 
 
 
2. V 
 
 
 
3.GN 
 
 
 
4. A 
 
 
 
 
 
5.C 
 
 
CONTROL GROUP 
1.K 
 
 
 
 
 
2.R 
 
 
 
 
3.B 
 
A small ulcer in I part of duo-
denum with marked oedema  
 
 
Deformed duodenum bulb 
with 2 small ulcer in anterior 
wall 
 
Moderate antral gastritis with 
an ulcer in I part and erosion  
  
 
A Small prepyloric ulcer seen 
wit oedematous pylorus 
 
 
 
 
Deformed pylorus hyperaemic 
erosion, an ulcer in I part of 
duodenum  
 
Lower end mild oesophagitis, 
antral gastritis, deformed 
pylorus, a small ulcer in I part  
 
 
 
Mild antral gastritis, an ulcer 
seen in ante. Wall wit mild 
bleeding, pylorus deformed & 
thickening of mucosal fold. 
 
Lower end oesophagitis, antral 
gastritis with erosion and a 
prepyloric ulcer with 
deformed and 
oedematouspylorus speed post  
 
Decreased sized of ulcer 
granulation tissue seen, 
oedema present  
 
No ulcer seen, same 
deformity present  
 
 
Oesophagus and 
stomach normal, mild 
duodenitis, no ulcer seen  
 
Healing of prepyloric 
ulcer seen with minimal 
granulation tissue and 
some oedema is 
persisting  
 
Not co-operated  
 
 
 
Oesophagus and 
stomach normal, mildly 
deformed pylorus, no 
ulcer some granulation 
tissue present  
 
Not Co-operated 
 
 
 
 
Oesophagus and 
stomach normal, no 
ulcer seen wit decreased 
oedema, granulation 
tissue present  
 
Partial Healing  
 
 
 
Good healing 
 
 
Good healing 
 
 
 
Good healing 
 
 
 
 
-- 
 
 
 
Marked healing  
 
 
 
 
-- 
 
 
 
 
Good healing  
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There is significant improvement in 
endoscopic findings in both trial and control 
group, despite the persistant radiological 
findings in some cases. 
 
It is not significant to calculate percentage 
of improvement in radiological and 
endoscopic findings, due to less number of 
case in peptic ulcer group. 
 
Discussion 
 
By considering the efficacy of Dhatri-lauha, 
it was decided to perform a study on 
scientific parameters and evaluate the 
efficacy of drug in parinamashoola, as, it has 
been already said tat clinical description of 
parinamashoola was gradually evolved in 
altter texts first of all, by madhavkar and 
further scientific input was added by 
vijayarakshita, Bhavprkasha & 
Yogaratnaker. 
 
Hundreds of therapeutic recipes are 
described in Ayurvedic classics for 
management of parinamashoola, Dhatrilauha 
is among such a formulae and contains three 
important ingredients, i.e. Amalaki, 
Yasthimadhu and lauha bhasma. Amalaki is 
a very popular drug and having wide range 
of actions., But in this regard, its ulcer 
healing, mucoprotective and enhance the 
effect of lauha are worth to be noted.   
Yasthimadhu (Liquorice) is also an effective 
ingredient, which has several actions, 
Anticholinergic, cytoprotective, ulcer 
healing are important to quote, lauha 
Bhasma has quality of Ramayana and also 
having pacifying effect of pitta and kappa 
Dhatrilauha is such a unique compound, 
which possess all such ingredients, by 
realizing all these unique qualities, 
Dhatrilauha is such a unique compound, 
which possess all such ingre3dients. B 
realizing all these unique qualities 
Dhatrilauha was taken for clinical evaluation 
under present study. 
 
Regarding the various observation, 
incidence of Age was most common in third 
and fourth decades in both the groups.  This 
can be due predominance of pitta. 
Observation of sex incidence, Non ulcer 
dyspepsia is more common in female cases 
(59.09%) tan males (40.91%) and peptic 
ulcer cases, ratio is equally distributed, stud 
of dehaprakriti showed maximum number of 
cases from vata- Paittika constitution in 
peptic ulcer an Non – ulcer dyspepsia both. 
 
Response of treatment was assessed in terms 
of clinical, radiological and endoscopic 
improvement, clinical improvement was 
calculated statistically and by reduction of 
mean difference of symptoms score (Table 
VII) 
 
Significant to highly significant 
improvement was found in symptom like 
pain in abdomen, acid eructation, vomiting, 
flatulence, heart burn and constipation etc, 
in all the groups of trial and control 
statistically.  B this results of certain 
symptoms was not significant (p >0.05), 
more in control group tan trial.  If ma be due 
to less number of cases in peptic ulcer and 
non ulcer dyspepsia of control group. 
 
It is found that trial drug (Dhatrilauha) was 
good to excellent response in almost all of 
the symptoms of peptic ulcer and non ulcer 
dyspepsia.  And control drug (Ranitidine) 
also showed similar results, but 
comparatively it was batter in some 
symptoms.  Total clinical response was also 
calculated in each patient and then 
percentage of reduction was calculated and 
it is shown in table No VIII. 
 
Radiological and endoscopic improvement 
was also assessed in positive cases of peptic 
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ulcer by repeat examination, Radiologically, 
there was mixed response from partial to 
good healing, it ma be due to tat, it requires 
long term treatment and further study., in 
repeat endoscopic examination, there was 
significant improvement in trial group and 
marked to good healing in cases of control 
group. 
 
Conclusion  
 
It can be concluded that, the present study 
proved the efficacy of Dhatri-lauha in 
management of parinamashoola (peptic 
Ulcer and Non Ulcer Dyspepsia). The mode 
of its action may be cytoprotective, 
antisecretary, increases the mucosal 
resistance and prokinetic action etc. 
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